 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/08/2026 |
$18.00 |
$18.34 |
$17.11 |
$17.28 |
238.30K | | 06/09/2026 |
$17.38 |
$18.23 |
$17.25 |
$18.00 |
126.20K | | 06/10/2026 |
$18.09 |
$18.76 |
$17.21 |
$17.57 |
169.10K | | 06/11/2026 |
$17.62 |
$19.04 |
$17.05 |
$18.34 |
139.30K | | 06/12/2026 |
$18.41 |
$19.05 |
$17.83 |
$17.92 |
182.00K |
 |
| GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. | |
 |

Crescent Biopharma (CBIO) has the following price history information. Looking back at CBIO historical stock prices for the last five trading days, on June 08, 2026, CBIO opened at $18.00, traded as high as $18.34 and as low as $17.11, and closed at $17.28. Trading volume was a total of 238.30K shares. On June 09, 2026, CBIO opened at $17.38, traded as high as $18.23 and as low as $17.25, and closed at $18.00. Trading volume was a total of 126.20K shares. On June 10, 2026, CBIO opened at $18.09, traded as high as $18.76 and as low as $17.21, and closed at $17.57. Trading volume was a total of 169.10K shares. On June 11, 2026, CBIO opened at $17.62, traded as high as $19.04 and as low as $17.05, and closed at $18.34. Trading volume was a total of 139.30K shares. On June 12, 2026, CBIO opened at $18.41, traded as high as $19.05 and as low as $17.83, and closed at $17.92. Trading volume was a total of 182.00K shares.
CBIO Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Crescent Biopharma shares, starting with a $10,000 purchase of CBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
06/14/2016 |
|
| End date: |
06/12/2026 |
|
| Start price/share: |
$10,785.00 |
|
| End price/share: |
$17.92 |
|
| Starting shares: |
0.93 |
|
| Ending shares: |
3.24 |
|
| Dividends reinvested/share: |
$167.00 |
|
| Total return: |
-99.42% |
|
| Average Annual Total Return: |
-40.25% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$57.99 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/14/2016 |
|
| End date: |
06/12/2026 |
|
| Start price/share: |
$10,785.00 |
|
| End price/share: |
$17.92 |
|
| Dividends collected/share: |
$167.00 |
|
| Total return: |
-98.29% |
|
| Average Annual Total Return: |
-33.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$171.43 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 06/08/2026 | $17.28 | | 06/09/2026 | $18.00 | | 06/10/2026 | $17.57 | | 06/11/2026 | $18.34 | | 06/12/2026 | $17.92 |
|
 |